Loss of EIF4G2 Mediates Aggressiveness in Distinct Human Endometrial Cancer Subpopulations with Poorer Survival Outcome in Patients
S. Meril, M. Muhlbauer Avni, C. Lior, M. Bhalsen, T. Olender, A. Savidor, J. Krausz, H. Belhanes Peled, H. Birisi, N. David, S. Bialik, R. Scherz-Shouval, Y. Ben David, A. Kimchi
This study shows that low EIF4G2 expression in Grade 2 endometrial cancer correlates with poor survival and drug resistance, suggesting it as a potential biomarker.
bioRxiv · Sep 14, 2023Cancer Biology